Video: “The Future of PSA Based Prostate Cancer (PCa) Screening – Screening Smarter and Individualized Risk Assessment”

January 2017 Awareness Night The Future of PSA Based Prostate Cancer (PCa) Screening – Screening Smarter and Individualized Risk Assessment Dr. Raj Satkunasivam, MD, MS, FRCSC Urologic Oncologist,  Odette Cancer Centre, Sunnybrook Health Sciences Centre Assistant Professor, Division of Urology, Department of Surgery, University of Toronto     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 40:51 minutes

Prostate Multiparametric MRI Feasible for PCa Screening

Robert K. Nam, MD, from the Sunnybrook Health Sciences Center in Toronto, and colleagues examined the feasibility of prostate MRI as the primary screening test for prostate cancer in a cohort of unselected men from the general population. All participants underwent prostate multiparametric MRI and random or targeted biopsies as well as prostate-specific antigen testing. Initial results showed that prostate MRI was better to predict prostate cancer than PSA. Read the article here.

New prostate cancer test strives to slash biopsies

Because PSA is secreted both by normal cells and cancer cells, its levels could be high for other reasons and not necessarily cancer: age, an inflammation of the prostate gland, or even a bicycle ride. But most often when doctors receive a high reading, they send their patients to do a biopsy, just to be on the safe side. Cleveland Diagnostics is developing a technology and test kit that can identify the PSA that specifically comes from cancer cells. Read the article here.

20th Anniversary Video

November 2014 Awareness Night – 20th Anniversary Celebration Watch this video of our 20th anniversary celebration: A bit of history from our founding as Man to Man to our joining the Prostate Cancer Canada Network Congratulatory messages from the medical community Our position on PSA testing as presented by PCC’s President and CEO Rocco Rossi   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 54:38 minutes

Landmark PSA Screening Trial Results Challenged

Recommendations against routine PSA screening from the US Preventive Services Task Force (USPSTF) are based largely on a landmark trial showing that such screening does not decrease the risk of death from prostate cancer (PCa), but this conclusion may be invalid. Read the article.

Video: “A twenty year personal reflection on the privilege of caring for men with prostate cancer”

May 2016 Awareness Night A twenty year personal reflection on the privilege of caring for men with prostate cancer Dr. Rajiv Singal,  MD, FRCSC Endourology, Urologic Cancer and Robotic Surgery Michael Garron Hospital Asst. Prof., Dept. of Surgery, U. of Toronto   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 39:36 minutes

Alcohol, especially liquor, increases prostate risk and skews PSA

A 2013 study published in the International Journal of Cancer raises concerns about alcohol’s ability to throw off prostate cancer tests. The investigators found a modestly higher risk of prostate cancer among heavy drinkers; they also observed evidence of lower PSA levels associated with increasing consumption of alcohol. This means it can be more difficult to detect prostate cancer using PSA levels among men who are heavy drinkers. In an older study of Harvard alumni, researchers concluded wine or beer consumption was unassociated with prostate cancer; however, moderate liquor consumption was associated with a significant 61-67 percent increased risk of …

Alcohol, especially liquor, increases prostate risk and skews PSA Read More »

Scroll to Top